Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.04%
12:00am, Tuesday, 16'th Jun 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.04%
AVEO Announces Proposed Public Offering of Common Stock
08:05pm, Monday, 15'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of $40.0 million of shares of its common stock. In connection with the offering, AVEO intends to gran
AVEO Announces Proposed Public Offering of Common Stock
12:00am, Monday, 15'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of $40.0 million of shares of its common stock. In
Jun 08, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Tyrosine Kinase Inhibitor Market”...
Aveo Oncology: Managing A Position Following Positive ASCO Data Readout (NASDAQ:AVEO)
06:29pm, Sunday, 07'th Jun 2020
Aveo recently presented their TIVO-3 data at ASCO that revealed Tivozanib's OS HR under 1.00. As a result, the company has received a PDUFA date on March 31st,
Hedge Funds Never Been Less Bullish On AVEO Pharmaceuticals, Inc. (AVEO)
11:01pm, Thursday, 04'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
FDA Okays AVEO's NDA Filing for Treating Renal Cell Carcinoma
03:41pm, Tuesday, 02'nd Jun 2020
AVEO's new drug application submission for tivozanib as a treatment of relapsed or refractory renal cell carcinoma gets acceptance from the FDA. A decision is expected on Mar 31, 2021.
Aveo’s Tivozanib Gets FDA Nod For New Drug Application To Treat Kidney Cancer
08:00am, Tuesday, 02'nd Jun 2020
Aveo Oncology (AVEO) announced that the U.S. Food and Drug Administration approved the New Drug Application (NDA) for its tivozanib used for the treatment of kidney cancer.Tivozanib is the company’s
UPDATE: AVEO Says Tivozanib Assigned PDUFA Target Action Date For Mar. 31, 2021
05:20pm, Monday, 01'st Jun 2020Shares Of AVEO Spike Higher After Company Issues Press Release On FDA Acceptance On Drug Application
05:16pm, Monday, 01'st Jun 2020
AVEO Oncology (NASDAQ: AVEO) today announced that the U.S. Food and Drug Administration (FDA) accepted for filing its New Drug Application (NDA) seeking approval for tivozanib, the Company’s next-ge
Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options
12:52pm, Monday, 01'st Jun 2020
Investors need to pay close attention to AVEO Pharmaceuticals (AVEO) stock based on the movements in the options market lately.
AVEO Oncology (NASDAQ: AVEO) today announced that the U.S. Food and Drug Administration (FDA) accepted for filing its New Drug Application (NDA) seeki
